Skip to main content

Profile hero

Profile details

About Joshua Samuel

Josh is an associate focusing on the representation of life sciences companies on corporate, transactional, and commercial matters.

Recent work

  • Moderna on a strategic collaboration and license of CytomX's Probody technology for use with Moderna's mRNA therapeutics, including a $35 million upfront cash payment and up to $1.2 billion in milestones.
  • Alexion, AstraZeneca Rare Disease on its acquisition of LogicBio® Therapeutics, Inc.



  • Columbia Law School
    • J.D., 2021
  • Texas A&M University
    • B.A., summa cum laude, 2018

Bar Admission

  • Admitted to the New York State Bar